More articles about: Rheumatology
Health Lab
Subset of COVID-19 Patients Have Increased Bleeding Risk
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
Health Lab
National research effort discovers relationship between inflammation, metabolism and scleroderma scarring
Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.
Health Lab
Protein Linked to Progressive Lung Scarring in Scleroderma Patients
Osteopontin is discovered as the culprit behind these patients’ main cause of death. However, a repurposed immunosuppressive drug may combat the pro-inflammatory protein.
Health Lab
New Cause of COVID-19 Blood Clots Identified
A new study reveals the COVID-19 virus triggers production of autoantibodies circulating through the blood, causing blood coagulation and clots in people hospitalized with the disease.
Health Lab
Gout Treatment Guidelines Revamped After New Clinical Guidance
The updated 2020 guidelines from the American College of Rheumatology focus on establishing a standard treat-to-target urate lowering therapy.
Health Lab
The Pandemic Fight Over Plaquenil
A patient with lupus weighs in on the COVID drug debate.
Health Lab
Half of Lupus Rashes Harbor High Levels of Bacteria Responsible for Infections
For patients with lupus, new study finds skin rashes may contain high levels of staph bacteria, which could be spreadable.
Health Lab
Scleroderma Support: Patients Find Help Online
A new website is helping patients with scleroderma learn more about the condition, how to manage their symptoms and self-advocacy strategies.
Health Lab
Exploring New Treatments for Autoimmune Diseases
A new grant will allow Michigan Medicine researchers to explore personalized approaches to treating autoimmune diseases such as scleroderma, lupus, rheumatoid arthritis and others.
Health Lab
Impeding White Blood Cells in Antiphospholipid Syndrome Reduced Blood Clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
Health Lab
Inhibiting Cancer-Causing Protein Could Prevent Scleroderma Fibrosis
Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients.
Health Lab
Systemic Scleroderma Treatments: Where Are We Now?
A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.
Health Lab
Skin’s Immune ‘Alarm’ May Explain Light-Induced Rashes in Lupus Patients
U-M researchers are studying an overabundant signaling protein tied to UV light sensitivity in patients with lupus.
Health Lab
Living with Scleroderma: Personalized Treatment, Support Makes All the Difference
A Michigan Medicine patient shares her experiences with the condition, and how she is now giving back through education and support for other patients.
Health Lab
How the Brain Plays a Role in Rheumatoid Arthritis Inflammation
A new study from researchers at Michigan Medicine explores links between chronic joint inflammation and cognitive impairment.
